ES516255A0 - "procedimiento de extraccion de una fraccion de mandassi (cyperus articulatus l.), activa como anti-convulsivante". - Google Patents

"procedimiento de extraccion de una fraccion de mandassi (cyperus articulatus l.), activa como anti-convulsivante".

Info

Publication number
ES516255A0
ES516255A0 ES516255A ES516255A ES516255A0 ES 516255 A0 ES516255 A0 ES 516255A0 ES 516255 A ES516255 A ES 516255A ES 516255 A ES516255 A ES 516255A ES 516255 A0 ES516255 A0 ES 516255A0
Authority
ES
Spain
Prior art keywords
mandassi
convulsivant
fraction
extraction
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES516255A
Other languages
English (en)
Other versions
ES8307100A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthelabo SA
Original Assignee
Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo SA filed Critical Synthelabo SA
Publication of ES516255A0 publication Critical patent/ES516255A0/es
Publication of ES8307100A1 publication Critical patent/ES8307100A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/89—Cyperaceae (Sedge family)
    • A61K36/8905—Cyperus (flatsedge)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ES516255A 1981-10-07 1982-10-06 "procedimiento de extraccion de una fraccion de mandassi (cyperus articulatus l.), activa como anti-convulsivante". Expired ES8307100A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8118891A FR2519551A1 (fr) 1981-10-07 1981-10-07 Composition pharmaceutique a base d'une fraction extraite de mandassi (cyperus articulatus l.)

Publications (2)

Publication Number Publication Date
ES516255A0 true ES516255A0 (es) 1983-06-16
ES8307100A1 ES8307100A1 (es) 1983-06-16

Family

ID=9262833

Family Applications (1)

Application Number Title Priority Date Filing Date
ES516255A Expired ES8307100A1 (es) 1981-10-07 1982-10-06 "procedimiento de extraccion de una fraccion de mandassi (cyperus articulatus l.), activa como anti-convulsivante".

Country Status (18)

Country Link
US (1) US4483852A (es)
EP (1) EP0076762B1 (es)
JP (1) JPS5874613A (es)
AR (1) AR229478A1 (es)
AT (1) ATE10907T1 (es)
AU (1) AU551840B2 (es)
CA (1) CA1194422A (es)
DE (1) DE3261711D1 (es)
ES (1) ES8307100A1 (es)
FR (1) FR2519551A1 (es)
GR (1) GR77716B (es)
IE (1) IE53980B1 (es)
IL (1) IL66936A (es)
MA (1) MA19617A1 (es)
NZ (1) NZ202094A (es)
OA (1) OA06933A (es)
PT (1) PT75650B (es)
ZA (1) ZA827334B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100863615B1 (ko) 2007-04-16 2008-10-15 바이오스펙트럼 주식회사 프리프리오카 오일을 함유하는 피부용 조성물
US20120009289A1 (en) * 2009-03-31 2012-01-12 Gbodossou Erick Vidjin Agnih Water-soluble antiviral product containing cyperus articulatus, for the treatment and prevention of acquired immunodeficiency syndrome (aids) and the variants thereof

Also Published As

Publication number Publication date
OA06933A (fr) 1983-07-31
IL66936A0 (en) 1983-02-23
NZ202094A (en) 1985-11-08
AU8917082A (en) 1983-04-14
PT75650A (fr) 1982-11-01
FR2519551B1 (es) 1984-03-16
CA1194422A (en) 1985-10-01
ATE10907T1 (de) 1985-01-15
GR77716B (es) 1984-09-25
AR229478A1 (es) 1983-08-31
MA19617A1 (fr) 1983-07-01
EP0076762B1 (fr) 1984-12-27
IE53980B1 (en) 1989-05-10
AU551840B2 (en) 1986-05-15
EP0076762A1 (fr) 1983-04-13
US4483852A (en) 1984-11-20
ZA827334B (en) 1983-08-31
PT75650B (fr) 1985-12-09
DE3261711D1 (en) 1985-02-07
FR2519551A1 (fr) 1983-07-18
IE822423L (en) 1983-04-07
JPS5874613A (ja) 1983-05-06
ES8307100A1 (es) 1983-06-16
IL66936A (en) 1985-08-30

Similar Documents

Publication Publication Date Title
IT8022284A0 (it) N-aril-ossazolidinoni e -pirrolidinoni, e procedimenti per la loro preparazione.
DK364683A (da) Sproejte, isaer til medicinsk anvendelse
IT8321016A0 (it) Procedimento per l'ottenimento dicomposti insaponificabili, apartire da sostanze naturali.
NO154165C (no) Fremgangsmaate ved fremstilling av 2,3,5-triklorpyridin.
NO166416C (no) Fremgangsmaate ved fremstilling av cellulosemasse.
NO153370C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive, stabile s-adenosylmethionisalter.
ES513147A0 (es) "un procedimiento de preparacion de complejos de acetaldehido asociados, estables, en solucion".
NO158061C (no) Fremgangsmaate for fremstilling av 4-hydroksy-2-metyl-n-2-pyridyl-2h-1,2-benzotiazin-3-karboksamid-1,1-dioksyd (piroxicam).
NO872156D0 (no) Fremgangsmaate ved opparbeidelse av batterier.
IT7926898A0 (it) Procedimento per preparare 1,2,3-tiadiazol-5-il-uree.
IT1206106B (it) Procedimento per preparare penemderivati otticamente attivi.
NO156113C (no) Tabletterbart, fast tannrensepreparat.
ES516255A0 (es) "procedimiento de extraccion de una fraccion de mandassi (cyperus articulatus l.), activa como anti-convulsivante".
AU530131B2 (en) Substituted benzoylimidates, for insecticidal use
NO885566D0 (no) Fremgangsmaate for fremstilling av poroese elektroder.
IT8220803A0 (it) Procedimento per la preparazione del 2,3-diidro-2,2-dimetilbenzofuran-7olo.
ES513883A0 (es) 10-(1-aza-(2,2,2)-biciclo-3-octil) 10 h-fenotiazin-2-sulfonamidas.
ES506814A0 (es) Procedimiento de preparacion de una 1-(trialcoxibencil)pi- perazina.
NO157142C (no) 6-fenyl-hydrazon-6,7,8,9-tetrahydro-11h-pyrido(2,1-b)kinazolin-11-oner.
ES523695A0 (es) Procedimiento de preparacion de derivados de eburnano-oxima racemicos u opticamente activos.
SU982006A1 (ru) Резервированное устройство
NO158062C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrido (1,4)benzodiazepiner.
NO863165D0 (no) Fremgangsmaate ved forbedret bekjempelse av rhinovirusinfeksjon.
FR2670116B1 (fr) Electrode, notamment electrode temporaire pour le cóoeur.
ES512696A0 (es) "procedimiento de obtener compuestos metilquinoxalin-1,4-dioxidicos".